CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Bio Protech Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Bio Protech Inc
151-3, Donghwagongdan-ro, Munmak-eup
Phone: +82 337357720p:+82 337357720 WONJU, 26365  South Korea Ticker: 199290199290
Business Summary
BIO PROTECH INC. is a Korea-based company mainly engaged in manufacture of medical equipment. The Company's products mainly consist of electrocardiogram electrodes, which are used for electrocardiogram tests, electrosurgery plates, electrosurgery pencils and transcutaneous electrical nerve stimulators (TENS) electrodes, which are used for providing conductive interface between the TENS generator and the patient’s skin.
(Source: 10-K405)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
3845 Electromedical and electrotherapeutic apparatus

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Co-Chief Executive Officer, Director Byeong JeonKim 50
Co-Chief Executive Officer, Director Yik RoPark 61
Assistant Managing Director Byeong TakLee 61
5 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 16,325,192 (As of 12/31/2023)
Shareholders: 271
Stock Exchange: KON
Fax Number: +82 337357736


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, November 22, 2024